Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.100EUR
−10.32 MEUR
7.86 MEUR
20.81 M
About ReShape Lifesciences, Inc.
Sector
Industry
CEO
Paul F. Hickey
Website
Headquarters
San Clemente
Employees (FY)
31
Founded
2002
FIGI
BBG00F0XFJB3
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band Adjustable Gastric Banding System, ReShape Marketplace, Obalon Balloon System, ReShape Vest, and Diabetes Bloc-Stim Neuromodulation device. It operates through the United States, Australia, Europe, and Rest of World geographical segments. The company was founded in December 2002 and is headquartered in San Clemente, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BER exchange RESHAPE LIFESCIENCES stocks are traded under the ticker 24O0.
24O0 reached its all-time high on Jan 3, 2023 with the price of 18.100 EUR, and its all-time low was 5.400 EUR and was reached on Dec 27, 2022. View more price dynamics on 24O0 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track RESHAPE LIFESCIENCES financials in yearly and quarterly reports right on TradingView.
RESHAPE LIFESCIENCES is going to release the next earnings report on Aug 12, 2024. Keep track of upcoming events with our Earnings Calendar.
RESHAPE LIFESCIENCES revenue for the last quarter amounts to 1.80 M EUR, despite the estimated figure of 1.95 M EUR. In the next quarter, revenue is expected to reach 2.06 M EUR.
24O0 net income for the last quarter is −2.03 M EUR, while the quarter before that showed −1.54 M EUR of net income which accounts for −32.11% change. Track more RESHAPE LIFESCIENCES financial stats to get the full picture.
No, 24O0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 1, 2024, the company has 31.00 employees. See our rating of the largest employees — is RESHAPE LIFESCIENCES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RESHAPE LIFESCIENCES EBITDA is −10.29 M EUR, and current EBITDA margin is −166.92%. See more stats in RESHAPE LIFESCIENCES financial statements.
Like other stocks, 24O0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RESHAPE LIFESCIENCES stock right from TradingView charts — choose your broker and connect to your account.